Shandong Sinobioway Biomedicine Co., Ltd. – a Sinobioway company, decided to build an antibody CMO site located in the Sinobioway biomedical industry park. The new CMO will offer complete manufacturing service, including research labs, 3×500L commercial production, 500L pivot scale, 200L pivot scale, formulation, storage and quality control. By 2023, it is expected to receive $471 million and have 500,000L capacity in the CMO. More details....
Stock Symbol: (SZEX: 002581)
Share this with colleagues:
Original Article: Sinobioway to Invest $471 Million Build a CMO Site in Hefei